0001213900-21-022386.txt : 20210421 0001213900-21-022386.hdr.sgml : 20210421 20210421113015 ACCESSION NUMBER: 0001213900-21-022386 CONFORMED SUBMISSION TYPE: RW PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20210421 DATE AS OF CHANGE: 20210421 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AIkido Pharma Inc. CENTRAL INDEX KEY: 0000012239 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 520849320 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: RW SEC ACT: SEC FILE NUMBER: 333-248072 FILM NUMBER: 21840141 BUSINESS ADDRESS: STREET 1: ONE ROCKEFELLER PLAZA, 11TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10020 BUSINESS PHONE: 347-321-7646 MAIL ADDRESS: STREET 1: ONE ROCKEFELLER PLAZA, 11TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10020 FORMER COMPANY: FORMER CONFORMED NAME: Aikido Pharma Inc. DATE OF NAME CHANGE: 20200317 FORMER COMPANY: FORMER CONFORMED NAME: SPHERIX INC DATE OF NAME CHANGE: 20010815 FORMER COMPANY: FORMER CONFORMED NAME: BIOSPHERICS INC DATE OF NAME CHANGE: 19920703 RW 1 ea139743_rw-alkidoph.htm FORM RW

 

AIkido Pharma Inc.

One Rockefeller Plaza
11th Floor
New York, New York, 10020

April 21, 2021

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, NE

Washington, D.C. 20549

 

     
  Re: AIkido Pharma Inc.
   

Request for Withdrawal Pursuant to Rule 477 of Registration Statement on Form S-1

(File No. 333-248072)

Ladies and Gentleman:

Pursuant to Rule 477 under the Securities Act of 1933, as amended, on behalf of AIkido Pharma Inc. (“we,” “us,” “our,” or the “Company”), we hereby submit this letter to notify the Securities and Exchange Commission (the “SEC”) of our withdrawal of our Registration Statement on Form S-1 (File No. 333-248072) (the “Registration Statement”), because the Company has elected to abandon the transactions subject thereto. The Registration Statement was not declared effective and no securities have been issued or sold under the Registration Statement.

Thank you for your assistance with this matter. If you have any questions or comments concerning this request, please call our legal counsel, Robert Charron, Esq. of Ellenoff Grossman & Schole LLP, at (212) 370-1300.

 

 

 

Sincerely,
 
/s/ Anthony Hayes
Anthony Hayes
Chief Executive Officer